VOAM
MDCO

Vertex One Asset Management’s Medicines Co MDCO Stock Holding History

Vertex One Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3.6M Buy
+42,400
New +$2.83M 0.83% 36

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vertex One Asset Management's MDCO Position: Q4 2019 in Review

Vertex One Asset Management opened a new position in Medicines Co (MDCO) in Q4 2019: 42,400 shares worth $3.6M. The stake represents 0.83% of the portfolio and ranks #36 among its holdings.

284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Vertex One Asset Management held 42,400 shares of Medicines Co worth $3.6M as of Q4 2019.
  • Medicines Co was a new Vertex One Asset Management position in Q4 2019.
  • Medicines Co made up 0.83% of Vertex One Asset Management's portfolio in Q4 2019, its #36 holding.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Vertex One Asset Management's 13F filing for Q4 2019, filed 21 Jan 2020.